查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662852

2030 年儿科医疗保健市场预测：按治疗类型、药物类型、年龄层、适应症、应用、最终用户和地区进行的全球分析

Paediatric Healthcare Market Forecasts to 2030 - Global Analysis By Treatment Type (Medications, Surgical Procedures, Preventive Care, Therapy and Other Treatment Types), Drug Type, Age Group, Indication, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球儿科医疗保健市场预计在 2024 年达到 147 亿美元，到 2030 年将达到 200 亿美元，预测期内的复合年增长率为 6.4%。

专业儿科保健部门为新生儿、婴儿和 18 岁以下的青少年提供医疗、治疗和预防服务。这包括新生儿护理、疫苗接种、疾病预防以及糖尿病、气喘和先天性疾病等长期问题的诊断、治疗和管理。营养咨询和疫苗接种计划是重要的预防干预措施。小儿科、护士和专家与父母合作，提供个人化的照护。随着远端医疗、医疗技术和人工智慧诊断的发展，全球获得优质儿科医疗保健的机会正在不断改善。

根据观察家研究基金会 2021 年 12 月发布的资料，印度约有 2 亿营养不良人口。感染疾病仍是全球五岁以下儿童死亡的主要原因。

慢性病增多

气喘、糖尿病和肥胖症等儿童慢性疾病需要持续的咨询和专门的护理，这增​​加了对儿科医疗保健服务的需求。此外，早期诊断和早期疗育对于管理慢性病至关重要，这进一步凸显了对先进诊断工具和治疗方案的需求。家长对儿童定期健康检查重要性的认识不断提高，这也促进了市场的成长。

治疗费用高且保险覆盖范围有限

对患有慢性或复杂疾病的儿童进行专门护理的费用可能非常昂贵，许多家庭无法负担他们所需的护理。此外，并非所有保险计划都完全涵盖儿科医疗保健服务，导致家庭自付的费用高昂。与治疗相关的经济负担使得父母无法为孩子获得及时和适当的治疗。改善保险覆盖范围和降低治疗成本的治疗方法对于确保所有儿童都能获得优质的医疗保健至关重要。

提高对儿童健康和营养的认识

父母和照顾者越来越认识到均衡饮食、定期运动和预防性保健对孩子的重要性。这种日益增强的认识推动了对健康教育计划、营养咨询和健康服务的需求。学校和社区团体也在鼓励儿童选择健康的生活方式方面发挥作用。因此，儿科保健提供者正在扩大其服务范围，包括针对儿童身体、心理和情绪健康的全面健康和保健计划。

小儿科短缺

小儿科、小儿科护理师和其他专业医疗保健专业人员的需求日益增长，但供应却无法满足。这种短缺可能会导致预约等待时间更长、获得专科护理的机会减少以及现有医疗保健提供者的业务增加。小儿科的短缺也可能影响儿童护理的质量，特别是那些患有复杂疾病且需要专业知识的儿童，从而阻碍市场成长。

COVID-19 的影响

COVID-19疫情对儿科医疗保健市场产生了重大影响。疫情导致非紧急医疗程序和常规检查被推迟，影响了整体儿科医疗使用率。然而，远距咨询和远端医疗服务的需求激增，为被封锁在室内的儿童提供了持续的医疗服务。这场疫情也提高了人们对儿童接种疫苗和预防性保健重要性的认识。

预计在预测期内，外科手术部分将成为最大的部分。

由于针对先天性缺陷、创伤和其他需要手术干预的情况的儿科手术数量的增加，预计在预测期内外科手术将占据最大的市场占有率。微创手术技术的进步和儿科患者专用手术器械的普及进一步促进了这一领域的成长。人们越来越意识到早期手术介入对于获得更好的健康结果的重要性，这也支持了对儿科手术的需求。

预计预测期内新生儿（0-28 天）部分的复合年增长率最高。

由于早产率上升和新生儿健康併发症增加导致对新生儿护理的关注度增加，预计新生儿（0-28 天）部分将在预测期内出现最高成长率。新生儿加护病房(NICU) 的进步和新生儿专用医疗设备的普及正在支持这一领域的扩张。此外，政府旨在降低新生儿死亡率和提高新生儿护理品质的措施和计划进一步推动了对新生儿医疗保健服务的需求。

比最大的地区

预计北美将在预测期内占据最大的市场占有率，这得益于该地区完善的医疗保健基础设施、高昂的医疗保健支出以及主要儿科医疗保健提供者的存在，从而占据主导地位。此外，儿童慢性病发病率的不断上升以及儿科专科护理需求的不断增长正在推动北美市场的成长。政府旨在改善儿童健康和降低婴儿死亡率的措施和政策进一步支持了儿童保健服务的扩大。

复合年增长率最高的地区

预计预测期内亚太地区将呈现最高的复合年增长率。该地区儿科医疗保健市场的快速成长是由慢性病盛行率的增加、医疗成本的上升以及医疗保健基础设施的不断扩大所推动的。中国和印度等国家处于这一增长的前沿，政府采取措施致力于改善儿童健康和降低婴儿死亡率。家长对儿童预防性保健和定期检查重要性的认识不断提高，进一步推动了市场扩张。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球儿科医疗保健市场按治疗类型划分

  • 介绍
  • 药物
  • 外科手术
  • 预防保健
  • 治疗
  • 其他的

6. 全球儿科医疗保健市场按药物类型划分

  • 介绍
  • 抗生素
  • 止痛药和止痛药
  • 退烧药
  • 抗过敏药物
  • 抗发炎药物
  • 抗病毒药物
  • 抗惊厥药
  • 化疗药物

7. 全球儿科医疗保健市场（按年龄层划分）

  • 介绍
  • 新生儿（0-28 天）
  • 婴儿（1个月至1岁）
  • 婴儿（1-3岁）
  • 学龄前儿童（3-5岁）
  • 学龄儿童（6-12岁）

8. 全球儿科医疗保健市场（按适应症）

  • 介绍
  • 气喘和过敏
  • 心臟病
  • 遗传性疾病
  • 糖尿病
  • 肥胖
  • 其他的

9. 全球儿科医疗保健市场（按应用）

  • 介绍
  • 小儿科专科护理
  • 急诊及严重治疗
  • 心理和行为健康
  • 居家医疗和远端医疗
  • 疾病的治疗和管理
  • 其他的

第 10 章 全球儿科医疗保健市场（按最终用户划分）

  • 介绍
  • 医院
  • 诊所和门诊中心
  • 研究和学术机构
  • 政府和非政府组织
  • 其他的

第 11 章。

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Abbott Laboratories
  • BAYADA Home Health Care
  • Boehringer Ingelheim International GmbH
  • BrightStar Care
  • Eisai Co.
  • Eli Lilly and Company
  • EnViva Paediatric Care
  • Gilead Sciences
  • GlaxosmithklinePlc
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc
  • Sanofi SA
  • Tendercare Home Health
  • The Procter & Gamble Company
  • Viatris
Product Code: SMRC28713

According to Stratistics MRC, the Global Paediatric Healthcare Market is accounted for $14.7 billion in 2024 and is expected to reach $20.0 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Providing medical care, treatment, and preventative services to newborns, kids, and teenagers up to the age of eighteen is the specialty of pediatric healthcare. Neonatal care, vaccinations, illness prevention, and the diagnosis, treatment, and management of long-term problems such as diabetes, asthma, and congenital disorders are all included. Nutritional counselling and immunization programs are important preventive interventions. To provide individualized care, paediatricians, nurses, and specialists work in tandem with parents. Global access to high-quality pediatric care has been enhanced by developments in telemedicine, medical technology, and AI-driven diagnostics.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders continue to be the primary causes of death among children under the age of five around the world.

Market Dynamics:

Driver:

Increasing prevalence of chronic illnesses

Chronic illnesses among children, such as asthma, diabetes, and obesity conditions require ongoing medical attention and specialized care, leading to a higher demand for paediatric healthcare services. Additionally, early diagnosis and intervention are critical for managing chronic illnesses, further emphasizing the need for advanced diagnostic tools and treatment options. The growing awareness among parents about the importance of regular health check-ups for their children is also contributing to the market's growth.

Restraint:

High treatment costs & limited insurance coverage

Specialized care for children with chronic illnesses or complex medical conditions can be prohibitively expensive, making it difficult for many families to afford the necessary treatments. Furthermore, not all insurance plans provide adequate coverage for paediatric healthcare services, leading to out-of-pocket expenses for families. The financial burden associated with medical treatments can deter parents from seeking timely and appropriate care for their children. Efforts to improve insurance coverage and reduce treatment costs are essential to ensure that all children have access to quality healthcare services.

Opportunity:

Increased awareness of child health & nutrition

Parents and caregivers are becoming more informed about the importance of a balanced diet, regular exercise, and preventive healthcare for their children. This heightened awareness is driving demand for health education programs, nutritional counselling, and wellness services. Schools and community organizations are also playing a role in promoting healthy lifestyle choices among children. As a result, paediatric healthcare providers are expanding their services to include comprehensive health and wellness programs that address the physical, mental, and emotional well-being of children.

Threat:

Shortage of paediatric specialists

The growing demand for paediatricians, paediatric nurses, and other specialized healthcare professionals is not being met with an adequate supply. This shortage can lead to longer wait times for appointments, reduced access to specialized care, and increased workloads for existing healthcare providers. The lack of paediatric specialists can also impact the quality of care provided to children, particularly those with complex medical conditions requiring specialized expertise impeding the market growth.

Covid-19 Impact

The COVID-19 pandemic has had a profound impact on the paediatric healthcare market. The pandemic led to the postponement of non-urgent medical procedures and routine check-ups, affecting overall healthcare utilization for children. However, the need for remote consultations and telehealth services surged, providing continued access to medical care for children during lockdowns. The pandemic also heightened awareness about the importance of vaccinations and preventive healthcare for children.

The surgical procedures segment is expected to be the largest during the forecast period

The surgical procedures segment is expected to account for the largest market share during the forecast period due to increasing number of paediatric surgeries for congenital anomalies, trauma, and other medical conditions requiring surgical intervention. Advances in minimally invasive surgical techniques and the availability of specialized surgical equipment for paediatric patients further contribute to the segment's growth. The rise in awareness about the importance of early surgical intervention for better health outcomes also supports the demand for paediatric surgical procedures.

The neonates (0-28 days) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neonates (0-28 days) segment is predicted to witness the highest growth rate owing to increasing focus on neonatal care, driven by rising preterm birth rates and neonatal health complications, is a key factor contributing to this growth. Advances in neonatal intensive care units (NICUs) and the availability of specialized medical equipment for newborns support the segment's expansion. Additionally, government initiatives and programs aimed at reducing neonatal mortality rates and improving the quality of care for newborns further drive the demand for neonatal healthcare services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to region's well-established healthcare infrastructure, high healthcare expenditure, and the presence of major paediatric healthcare providers contribute to its dominant position. Additionally, the increasing prevalence of chronic illnesses among children and the rising demand for specialized paediatric care drive the market growth in North America. Government initiatives and policies aimed at improving child health and reducing infant mortality rates further support the expansion of paediatric healthcare services.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR attributed rapid growth of the paediatric healthcare market in this region is driven by the increasing prevalence of chronic illnesses, rising healthcare expenditure, and the expansion of healthcare infrastructure. Countries like China and India are at the forefront of this growth, with government initiatives aimed at improving child health and reducing infant mortality rates. The growing awareness among parents about the importance of preventive healthcare and regular check-ups for children further supports the market expansion.

Key players in the market

Some of the key players in Paediatric Healthcare market include Abbott Laboratories, BAYADA Home Health Care, Boehringer Ingelheim International GmbH, BrightStar Care, Eisai Co., Eli Lilly and Company, EnViva Paediatric Care, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Novartis International AG, Pfizer Inc, Sanofi S A, Tendercare Home Health, The Procter & Gamble Company and Viatris.

Key Developments:

In January 2025, Eli Lilly and Company and Scorpion Therapeutics, Inc announced a definitive agreement for Lilly to acquire Scorpion's PI3Ka inhibitor program STX-478. STX-478 is a once-daily oral, mutant-selective PI3Ka inhibitor currently being evaluated in a Phase 1/2.

In January 2025, Johnson & Johnson and Intra-Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies.

In December 2024, Abbott announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring products.

Treatment Types Covered:

  • Medications
  • Surgical Procedures
  • Preventive Care
  • Therapy
  • Other Treatment Types

Drug Types Covered:

  • Antibiotics
  • Analgesics and Pain Medications
  • Antipyretics
  • Antiallergy Drugs
  • Anti-inflammatory Drugs
  • Antiviral Drugs
  • Anticonvulsants
  • Chemotherapy Drugs

Age Groups Covered:

  • Neonates (0-28 days)
  • Infants (1 month - 1 year)
  • Toddlers (1-3 years)
  • Preschoolers (3-5 years)
  • School-aged Children (6-12 years)

Indications Covered:

  • Asthma & Allergies
  • Cardiac Disorders
  • Genetic Disorders
  • Diabetes
  • Obesity
  • Other Indications

Applications Covered:

  • Paediatric Specialty Care
  • Emergency & Critical Care
  • Mental & Behavioural Health
  • Home Healthcare & Telemedicine
  • Disease Treatment & Management
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics & Ambulatory Care Centres
  • Research & Academic Institutions
  • Government & Non-Governmental Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Paediatric Healthcare Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Medications
  • 5.3 Surgical Procedures
  • 5.4 Preventive Care
  • 5.5 Therapy
  • 5.6 Other Treatment Types

6 Global Paediatric Healthcare Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Antibiotics
  • 6.3 Analgesics and Pain Medications
  • 6.4 Antipyretics
  • 6.5 Antiallergy Drugs
  • 6.6 Anti-inflammatory Drugs
  • 6.7 Antiviral Drugs
  • 6.8 Anticonvulsants
  • 6.9 Chemotherapy Drugs

7 Global Paediatric Healthcare Market, By Age Group

  • 7.1 Introduction
  • 7.2 Neonates (0-28 days)
  • 7.3 Infants (1 month - 1 year)
  • 7.4 Toddlers (1-3 years)
  • 7.5 Preschoolers (3-5 years)
  • 7.6 School-aged Children (6-12 years)

8 Global Paediatric Healthcare Market, By Indication

  • 8.1 Introduction
  • 8.2 Asthma & Allergies
  • 8.3 Cardiac Disorders
  • 8.4 Genetic Disorders
  • 8.5 Diabetes
  • 8.6 Obesity
  • 8.7 Other Indications

9 Global Paediatric Healthcare Market, By Application

  • 9.1 Introduction
  • 9.2 Paediatric Specialty Care
  • 9.3 Emergency & Critical Care
  • 9.4 Mental & Behavioural Health
  • 9.5 Home Healthcare & Telemedicine
  • 9.6 Disease Treatment & Management
  • 9.7 Other Applications

10 Global Paediatric Healthcare Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Clinics & Ambulatory Care Centres
  • 10.4 Research & Academic Institutions
  • 10.5 Government & Non-Governmental Organizations
  • 10.6 Other End Users

11 Global Paediatric Healthcare Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 BAYADA Home Health Care
  • 13.3 Boehringer Ingelheim International GmbH
  • 13.4 BrightStar Care
  • 13.5 Eisai Co.
  • 13.6 Eli Lilly and Company
  • 13.7 EnViva Paediatric Care
  • 13.8 Gilead Sciences
  • 13.9 GlaxosmithklinePlc
  • 13.10 Johnson & Johnson
  • 13.11 Novartis International AG
  • 13.12 Pfizer Inc
  • 13.13 Sanofi S A
  • 13.14 Tendercare Home Health
  • 13.15 The Procter & Gamble Company
  • 13.16 Viatris

List of Tables

  • Table 1 Global Paediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Paediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Paediatric Healthcare Market Outlook, By Medications (2022-2030) ($MN)
  • Table 4 Global Paediatric Healthcare Market Outlook, By Surgical Procedures (2022-2030) ($MN)
  • Table 5 Global Paediatric Healthcare Market Outlook, By Preventive Care (2022-2030) ($MN)
  • Table 6 Global Paediatric Healthcare Market Outlook, By Therapy (2022-2030) ($MN)
  • Table 7 Global Paediatric Healthcare Market Outlook, By Other Treatment Types (2022-2030) ($MN)
  • Table 8 Global Paediatric Healthcare Market Outlook, By Drug Type (2022-2030) ($MN)
  • Table 9 Global Paediatric Healthcare Market Outlook, By Antibiotics (2022-2030) ($MN)
  • Table 10 Global Paediatric Healthcare Market Outlook, By Analgesics and Pain Medications (2022-2030) ($MN)
  • Table 11 Global Paediatric Healthcare Market Outlook, By Antipyretics (2022-2030) ($MN)
  • Table 12 Global Paediatric Healthcare Market Outlook, By Antiallergy Drugs (2022-2030) ($MN)
  • Table 13 Global Paediatric Healthcare Market Outlook, By Anti-inflammatory Drugs (2022-2030) ($MN)
  • Table 14 Global Paediatric Healthcare Market Outlook, By Antiviral Drugs (2022-2030) ($MN)
  • Table 15 Global Paediatric Healthcare Market Outlook, By Anticonvulsants (2022-2030) ($MN)
  • Table 16 Global Paediatric Healthcare Market Outlook, By Chemotherapy Drugs (2022-2030) ($MN)
  • Table 17 Global Paediatric Healthcare Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 18 Global Paediatric Healthcare Market Outlook, By Neonates (0-28 days) (2022-2030) ($MN)
  • Table 19 Global Paediatric Healthcare Market Outlook, By Infants (1 month - 1 year) (2022-2030) ($MN)
  • Table 20 Global Paediatric Healthcare Market Outlook, By Toddlers (1-3 years) (2022-2030) ($MN)
  • Table 21 Global Paediatric Healthcare Market Outlook, By Preschoolers (3-5 years) (2022-2030) ($MN)
  • Table 22 Global Paediatric Healthcare Market Outlook, By School-aged Children (6-12 years) (2022-2030) ($MN)
  • Table 23 Global Paediatric Healthcare Market Outlook, By Indication (2022-2030) ($MN)
  • Table 24 Global Paediatric Healthcare Market Outlook, By Asthma & Allergies (2022-2030) ($MN)
  • Table 25 Global Paediatric Healthcare Market Outlook, By Cardiac Disorders (2022-2030) ($MN)
  • Table 26 Global Paediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
  • Table 27 Global Paediatric Healthcare Market Outlook, By Diabetes (2022-2030) ($MN)
  • Table 28 Global Paediatric Healthcare Market Outlook, By Obesity (2022-2030) ($MN)
  • Table 29 Global Paediatric Healthcare Market Outlook, By Other Indications (2022-2030) ($MN)
  • Table 30 Global Paediatric Healthcare Market Outlook, By Application (2022-2030) ($MN)
  • Table 31 Global Paediatric Healthcare Market Outlook, By Paediatric Specialty Care (2022-2030) ($MN)
  • Table 32 Global Paediatric Healthcare Market Outlook, By Emergency & Critical Care (2022-2030) ($MN)
  • Table 33 Global Paediatric Healthcare Market Outlook, By Mental & Behavioural Health (2022-2030) ($MN)
  • Table 34 Global Paediatric Healthcare Market Outlook, By Home Healthcare & Telemedicine (2022-2030) ($MN)
  • Table 35 Global Paediatric Healthcare Market Outlook, By Disease Treatment & Management (2022-2030) ($MN)
  • Table 36 Global Paediatric Healthcare Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 37 Global Paediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 38 Global Paediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 39 Global Paediatric Healthcare Market Outlook, By Clinics & Ambulatory Care Centres (2022-2030) ($MN)
  • Table 40 Global Paediatric Healthcare Market Outlook, By Research & Academic Institutions (2022-2030) ($MN)
  • Table 41 Global Paediatric Healthcare Market Outlook, By Government & Non-Governmental Organizations (2022-2030) ($MN)
  • Table 42 Global Paediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.